Previously, morphine and fentanyl—nonpeptide agonists of μ-opioid receptors—have been reported to increase SIRT1 expression in the mouse brain [41] and to inhibit NF-κB in cancer cells in a SIRT1-dependent manner [42], respectively. Here, NFKB1 is linked to cancer.